Medicaid coverage
Ohio: what Medicaid covers
Ohio files Wegovy under a class titled "GLP-1 agonists for non-obesity indications", and sets out prior-authorization criteria for cardiovascular events and MASH only. Continuing an authorization requires documented weight loss of at least 5% from baseline.
| Drug | Position | Criteria |
|---|---|---|
| Semaglutide | Other indications only | Listed only under "GLP-1 agonists for non-obesity indications". Prior authorization for cardiovascular events or MASH |
| Tirzepatide | not checked | Not named in the unified list, which states it is not an all-inclusive list of covered drugs |
| Liraglutide | not checked | Not named in the unified list, which states it is not an all-inclusive list of covered drugs |
-
Semaglutide Other indications only
Listed only under "GLP-1 agonists for non-obesity indications". Prior authorization for cardiovascular events or MASH
-
Tirzepatide not checked
Not named in the unified list, which states it is not an all-inclusive list of covered drugs
-
Liraglutide not checked
Not named in the unified list, which states it is not an all-inclusive list of covered drugs
Sources
Every claim above is checked against the primary text, and the date is the day we last opened it.
-
1
Ohio Medicaid Unified Preferred Drug List
Ohio Department of Medicaid Primary text read and checked Checked August 25, 2026